Sign Up to like & get
recommendations!
2
Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34149
Abstract: The IDEA trial showed no clinical relevant differences in efficacy between 3 and 6 months of oxaliplatinâbased adjuvant chemotherapy (ACT) in colon cancer (CC), while toxicity was substantially lower in the 3 months regimen. Therefore,…
read more here.
Keywords:
guideline;
act;
stage;
idea trial ... See more keywords